UK MHRA updates guidance on devices with ancillary medicinal substances
This article was originally published in Clinica
Executive Summary
The UK Medicines and Healthcare Products Agency has revised its guidance for notified bodies wanting to consult the agency with regard to medical devices incorporating ancillary medicinal substances.